期刊文献+

丙泊酚靶控输注复合瑞芬太尼喉罩全麻在宫腔镜手术中的应用 被引量:10

Application of target control infusion of propofol and remifentanyl with laryngeal mask anesthesia insertion in hysteroscopic electrocision
下载PDF
导出
摘要 目的观察丙泊酚靶控输注复合瑞芬太尼全麻在宫腔镜手术中应用的安全性和有效性。方法选择ASAⅠ级或Ⅱ级择期行宫腔镜手术的患者60例,随机分为丙泊酚复合瑞芬太尼组(R组)和丙泊酚复合芬太尼组(F组),每组30例。记录麻醉前、麻醉后5 min、10 min和停药后10 min的DBP、SBP、HR、SpO2,记录患者手术时间、苏醒时间、离室时间、丙泊酚用量、不良反应发生情况。结果两组均顺利完成手术,无严重不良反应发生。两组患者在麻醉后5 min、10 min的SBP和DBP较术前下降明显(P<0.05)。R组患者苏醒时间和离开手术室时间较F组短(P<0.01)。结论靶控输注丙泊酚复合瑞芬太尼喉罩全麻应用于妇科宫腔镜手术,苏醒迅速,安全有效。 Objective To investigate the security and effectiveness of target control infusion(TCI) of propofol and remifentanil with laryngeal mask anesthesia(LMA) insertion in hysteroscopic electrocision.Methods Sixty cases of ASA I and II grade were collected and randomly divided into two groups:group of remifentanil(group R) and group of fentanyl(group F).The DBP,SBP,HR,SpO2 of the patients were recorded before induction,5 min,10 min after induction,and 10 min after operation.Then the operation time,the analepsia time,and the postoperative complications were observed in these two groups.Results The anesthesia of all cases were satisfactory,and no accidence or complication was observed.DBP,SBP at 5 min,10 min after induction were significantly lowered compared with those before operation(P0.05).The analepsia time and departing operation time of group R were shorter than those of group F(P0.01).Conclusion The method of TCI of propofol and remifentanil with LMA insertion in the application of hysteroscopic electrocision is effective and safe,and with the advantage of rapid recovery.
作者 解翔彬 陈霞
出处 《微创医学》 2011年第3期213-215,共3页 Journal of Minimally Invasive Medicine
关键词 丙泊酚 瑞芬太尼 全身麻醉 靶控输注 宫腔镜手术 Propofol Remifentanil General anesthesia Target control infusion(TCI) Hysteroscopic electrocision surgery
  • 相关文献

参考文献8

二级参考文献34

  • 1李晓松,路红梅,刘雅.静吸复合麻醉用于腹腔镜胆囊切除术时雷米芬太尼与芬太尼的比较[J].临床麻醉学杂志,2005,21(3):201-202. 被引量:51
  • 2王强,谭冠先.瑞芬太尼在微创医学中的应用[J].微创医学,2007,2(2):130-132. 被引量:6
  • 3赵申明 张立生 倪家骧.七氟醚吸入麻醉对心血管功能的影响[J].中华麻醉学杂志,1996,16(4):190-190.
  • 4Wallin R F, Regan B M, Napoli M D, et al. sevoflurance: a new inhalational anesthetic agent [J]. Anesth A nalg, 1975, 54 (6) : 758.
  • 5Akazawa S, Shimizu R, Kasuda H, et al. Effects of sevoflurane on cardiouscrlar dynamics, coronary circulation and myocardial Metabolism in dogs [J]. J Anesth, 1988, 2(2):227-241.
  • 6Green W B, Jr. The ventilatory efects of sevoflurane [J]. Anesth Analg, 1995, 81 (6 Suppl) : 523-526.
  • 7Pandin PC, Cantraine F, Ewalenko P, et al. Predictive accuracy of target-controlled propofol and sufentnit coinfusion in long-lasting surgery [ J ]. Anesthesiology, 2000,93 ( 3 ) : 653 - 661.
  • 8Frolieh MA, Dennis DM, Shrster JA, et al. Precision and bias of target controlled propofol infusion for sedation [ J ]. BJA, 2005,94 ( 4 ) : 434 - 437.
  • 9Mertens M J, Olofsen E, Engbers FH, et, al. Propofol reduces periopera-tire remifentanil requirements in a synergistic manner: response surface modeling of perioperative emifentanil-propofol interactions [J]. Anesthesiology,2003, 99(2) :347 -349.
  • 10[1]Feldman PL,James MK,Grackeen MF,et al.Design,synthesis,and pharmacological evaluation of ultrashort to Jong-acting opioid analgesics[J].Med Chem,1991,34(7):2202-2208.

共引文献104

同被引文献36

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部